Eidelberg, Andrew
Axelrad, Jordan
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK124570)
Article History
Received: 29 July 2025
Accepted: 22 August 2025
First Online: 8 October 2025
Declarations
:
: AE with no disclosures. JA has received research grants from BioFire Diagnostics, Genentech, Janssen, and Takeda; consultancy fees, honorarium, or advisory board fees from Abbvie, Abivax, Adiso, Biomerieux, Bristol-Myers Squibb, Celltrion, Ferring, Fresenius, Janssen, Merck, Pfizer, Sanofi, Takeda, and Vedanta.
: JA has received research grants from BioFire Diagnostics, Genentech, Janssen, and Takeda; consultancy fees, honorarium, or advisory board fees from Abbvie, Abivax, Adiso, Biomerieux, Bristol-Myers Squibb, Celltrion, Ferring, Fresenius, Janssen, Merck, Pfizer, Sanofi, Takeda, and Vedanta.